Chemopreventive activity of oltipraz

Pharmacology and Therapeutics

Volumn 78, Issue 1, 1998, Pages 17-27

  Clapper, Margie L ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Animal models; Chemoprevention; Clinical trials; Detoxification enzyme inducer; Oltipraz

Indexed keywords

OLTIPRAZ;

ABDOMINAL PAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DETOXIFICATION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MECHANISM; FATIGUE; FLATULENCE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NAUSEA; NONHUMAN; ORAL DRUG ADMINISTRATION; PHOTOSENSITIVITY; PRIORITY JOURNAL; RAT; REVIEW; SCHISTOSOMIASIS; SOMNOLENCE; SYRIAN HAMSTER; TRANSCRIPTION REGULATION;

ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; BIOLOGICAL AVAILABILITY; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; ENZYME INDUCTION; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE TRANSFERASE; HUMANS; NAD(P)H DEHYDROGENASE (QUINONE); PYRAZINES; REVERSE TRANSCRIPTASE INHIBITORS; SCHISTOSOMICIDES; TISSUE DISTRIBUTION;

EID: 0031969218     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(97)00164-2     Document Type: Review

References (59)

1. Ali H. M., Homeida M. M., Sulaiman S. M., Bennett J. L. Diet-controlled blood levels of oltipraz in healthy male subjects. J. Antimicrob. Chemother. 13:1984;465-470.
2. Anderson L., Steele V. K., Kelloff G. J., Sharma S. Effects of oltipraz and related chemoprevention compounds on gene expression in rat liver. J. Cell. Biochem. 22(Suppl.):1995;108-116.
3. Anonymous Oltipraz - Definitely withdrawn. Parasitol. Today. 1:1985;100.
4. Ansher S. S., Dolan P., Bueding E. Chemoprotective effects of two dithiolthiones and of butylhydroxyanisole against carbon tetrachloride and acetaminophen toxicity. Hepatology. 3:1983;932-935.
5. Ansher S. S., Dolan P., Bueding E. Biochemical effects of dithiolthiones. Food Chem. Toxicol. 24:1986;405-415.
6. Benson A. B., Mobarhan S., Ratain M., Sheehan T., Berezin F., Giovannozzi-Bannon S., Ford C., Rademaker A. Phase I study of 4-methyl-5-(2-pyrazinyl)-1,2-dithiol-3-thione (oltipraz, RP 35972) in male patients (pts) with previously resected colon polyps and first degree relatives of breast cancer pts. Proc. Am. Soc. Clin. Oncol. 11:1992;145.
7. Bieder A., Decouvelaere B., Gaillard C., Depaire H., Heusse D., Ledoux C., Lemar M., LeRoy J. P., Raynaud L., Snozzi C., Gregoire J. Comparison of the metabolism of oltipraz in the mouse, rat, and monkey and in man. Arzneimittelforschung (Drug Res.). 33:1983;1289-1297.
8. Boone C. W., Steele V. E., Kelloff G. J. Screening for chemopreventive (anticarcinogenic) compounds in rodents. Mutat. Res. 267:1992;251-255.
9. Bueding E., Dolan P., Leroy J. P. The antischistosomal activity of oltipraz. Res. Commun. Chem. Pathol. Pharmacol. 37:1982;293-303.
10. Buetler T. M., Gallagher E. P., Wang C., Stahl D. L., Hayes J. D., Eaton D. L. Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. Toxicol. Appl. Pharmacol. 135:1995;45-47.
11. Buetler T. M., Bammler T. K., Hayes J. D., Eaton D. L. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver. implications for human chemointervention Cancer Res. 56:1996;2306-2313.
12. Chavan S. J., Bornmann W. G., Flexner C., Prochaska H. J. Inactivation of human immunodeficiency virus Type 1 reverse transcriptase by oltipraz. evidence for the formation of a stable adduct Arch. Biochem. Biophys. 324:1995;143-152.
13. Clapper M. L., Everley L. C., Strobel L. A., Townsend A. J., Engstrom P. F. Coordinate induction of glutathione S-transferase α, μ, and π expression in murine liver after a single administration of oltipraz. Mol. Pharmacol. 45:1994;469-474.
14. Clapper M. L., Wood M., Leahy K., Lang D., Miknyoczki S., Ruggeri B. A. Chemopreventive activity of oltipraz against N-nitrosobis(2-oxopropyl)amine (BOP)-induced ductal pancreatic carcinoma development and effects on survival of Syrian golden hamsters. Carcinogenesis. 16:1995;2159-2165.
15. 1 by glutathione and glutathione transferases in vitro. Carcinogenesis. 6:1985;693-697.
16. Davidson N. E., Egner P. A., Kensler T. W. Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1, 2-dithiole-3-thione (Oltipraz) in rat liver. Cancer Res. 50:1990;2251-2255.
17. Davies M. H., Blacker A. M., Schnell R. C. Dithiolthione-induced alterations in hepatic glutathione and related enzymes in male mice. Biochem. Pharmacol. 36:1987;568-570.
18. DeLong M. J., Dolan P., Santamaria A. B., Bueding E. 1,2-Dithiol-3-thione analogs. effects of NAD(P)H: quinone oxidoreductase and glutathione levels in murine hepatoma cells Carcinogenesis. 7:1986;977-980.
19. Dimitrov N. V., Bennett J. L., McMillan J., Perloff M., Leece C. M., Malone W. Clinical pharmacology studies of Oltipraz - A potential chemopreventive agent. Invest. New Drugs. 10:1992;289-298.
20. Egner P. A., Kensler T. W., Prestera T., Talalay P., Libby A. H., Joyner H. H., Curphey T. J. Regulation of phase 2 enzyme induction by oltipraz and other dithiolthiones. Carcinogenesis. 15:1994;177-181. a.
21. Egner P. A., Primiano T., Dolan P. M., Kensler T. W., Libby A. H., Joyner H. H., Curphey T. J. Structure activity relationship of phase 2 induction in vivo by oltipraz and related dithiolethiones. Proc. Am. Assoc. Cancer Res. 35:1994;627. b.
22. Ellis E. M., Judah D. J., Neal G. E., O'Connor T., Hayes J. D. Regulation of carbonyl-reducing enzymes in rat liver by chemoprotectors. Cancer Res. 56:1996;2758-2766.
23. Gentilini M., Duflo B., Richard-Lenoble D., Brucker G., Danis M., Niel G., Meunier Y. Assessment of RP 35972 (oltipraz), a new antischistosomal drug against schistosoma hematobium, schistosoma mansoni and schistosoma intercalatum. Acta Trop. 37:1980;271-274.
24. Gupta E., Olopade O. I., Ratain M. J., Mick R., Baker T. M., Berezin F. K., Benson A. B., Dolan M. E. Pharmacokinetics and pharmacodynamics of Oltipraz as a chemopreventive agent. Clin. Cancer Res. 1:1995;1133-1138.
25. Halbherr T., Yao K.-S., Myers C., Glusker J. P., Clayton M., O'Dwyer P. J. Induction of detoxicating enzyme expression by metabolites of 4-methyl-5-(2-pyrazinyl)-1, 2-dithiole-3-thione (oltipraz). Proc. Am. Assoc. Cancer Res. 36:1995;591.
26. Helmes C. T., Becker R. A., Seidenberg J. M., Schindler J. E., Kelloff G. Chemoprevention of mouse skin tumorgenesis by dietary oltipraz. Proc. Am. Assoc. Cancer Res. 30:1989;177.
27. Jacobson L. P., Zhang B.-C., Zhu Y.-R., Wang J.-B., Wu Y., Zhang Q.-N., Yu L.-Y., Qian G.-S., Kuang S. Y., Li Y.-F., Fang X., Zarba A., Chen B., Enger C., Davidson N. E., Gorman M. B., Gordon G. B., Prochaska H. J., Egner P. A., Groopman J. D., Muñoz A., Helzlsouer K. J., Kensler T. W. Oltipraz chemoprevention trial in Qidong, People's Republic of China. study design and clinical outcomes Cancer Epidemiol. Biomarkers Prev. 6:1997;257-265.
28. Katz N., Rocha R. S., Chaves A. Dose-ranging clinical trial with oltipraz in schistosomiasis mansoni. Rev. Inst. Med. Trop. Sao Paolo. 24:1982;40-48.
29. Katz N., Rocha R. S., Chaves A. Assessment of oltipraz in schistosomiasis mansoni. clinical trial Rev. Inst. Med. Trop. Sao Paolo. 26:1984;147-151.
30. Kelloff G. J., Boone C. W., Crowell J. A., Steele V. E., Lubet R., Sigman C. C. Chemopreventive drug development. perspectives and progress Cancer Epidemiol. Biomarkers Prev. 3:1994;85-98.
31. 1 binding to DNA in vivo rats fed phenolic antioxidants, ethoxyquin and a dithiolthione. Carcinogenesis. 6:1985;759-763.
32. Kensler T. W., Egner P. A., Dolan P. M., Groopman J. D., Roebuck B. D. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1, 2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res. 47:1987;4271-4277.
33. 1 metabolism in human hepatocytes in primary culture. Cancer Res. 55:1995;5574-5579.
34. Liu T., Mokuolu A. O., Rao C. V., Reddy B. S., Holt P. R. Regional chemoprevention of carcinogen-induced tumors in rat colon. Gastroenterology. 109:1995;1167-1172.
35. 1 in the rat. Toxicol. Appl. Pharmacol. 93:1988;442-451.
36. 1-induced preneoplastic foci in a rat model of hepatic tumorigenesis. Carcinogenesis. 14:1993;2423-2425.
37. Mehta R. G., Moon R. C. Characterization of effective chemopreventive agents in mammary gland in vitro using an initiation-promotion protocol. Anticancer Res. 11:1991;593-596.
38. Meyer D. J., Harris J. M., Gilmore K. S., Coles B., Kensler T. W., Ketterer B. Quantitation of tissue- and sex-specific induction of rat GSH transferase subunits by dietary 1,2-dithiole-3-thiones. Carcinogenesis. 14:1993;567-572.
39. Moon R. C., Kelloff G. J., Detrisac C. J., Steele V. E., Thomas C. F., Sigman C. C. Chemoprevention of OH-BBN-induced bladder cancer in mice by oltipraz, alone and in combination with 4-HPR and DFMO. Anticancer Res. 14:1994;5-12. a.
40. Moon R. C., Rao K. V. N., Detrisac C. J., Kelloff G. J., Steele V. E., Doody L. A. Chemoprevention of respiratory tract neoplasia in the hamster by oltipraz, alone and in combination. Int. J. Oncol. 4:1994;661-667. b.
41. Moreau N., Martens T., Fleury M.-B., Leroy J.-P. Metabolism of oltipraz and glutathione reductase inhibition. Biochem. Pharmacol. 40:1990;1299-1305.
42. Morel F., Fardel O., Meyer D. J., Langouet S., Gilmore K. S., Meunier B., Tu C.-P. D., Kensler T. W., Ketterer B., Guillouzo A. Preferential increase of glutathione S-transferase class α transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene, and dithiolethiones. Cancer Res. 53:1993;231-234.
43. Morse M. A., Zu H., Kresty L. A., Stoner G. D. Failure of dietary oltipraz to inhibit benzo[a]pyrene-induced lung tumorigenesis in strain A mice. Cancer Lett. 91:1995;133-138.
44. O'Dwyer P. J., Szarka C. E., Gallo J. M., Yao K.-S., Hum S. T., Greene F., Halbherr T. C., Brennan J., Pfeiffer G. R., Frucht H., Goosenberg R. B., Engstrom P. F., Clapper M. L. Phase I/pharmacodynamic trial of the chemopreventive agent oltipraz. Proc. Am. Soc. Clin. Oncol. 13:1994;144.
45. O'Dwyer P. J., Szarka C. E., Yao K.-S., Halbherr T. C., Pfeiffer G. R., Green F., Gallo J. M., Brennan J., Frucht H., Goosenberg E. B., Hamilton T. C., Litwin S., Balshem A. M., Engstrom P. F., Clapper M. L. Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. J. Clin. Invest. 98:1996;1210-1217.
46. Pepin P., Bouchard L., Nicole P., Castonguay A. Effects of sulindac and oltipraz on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Carcinogenesis. 13:1992;341-348.
47. Primiano T., Egner P. A., Sutter T. R., Kelloff G. J., Roebuck B. D., Kensler T. W. Intermittent dosing with oltipraz-relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases. Cancer Res. 55:1995;4319-4324.
48. Prochaska H. J., Talalay P. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res. 48:1988;4776-4782.
49. Prochaska H. J., Bornmann W. G., Baron P., Polsky B. Inhibition of human immunodeficiency virus Type I replication by 7-methyl-6,8-bis(methylthio)pyrrolo[1,2-a]pyrazine, an in vivo metabolite of oltipraz. Mol. Pharmacol. 48:1995;15-20.
50. Prochaska H. J., Pernandes C. L., Pantoja R. M., Chavan S. J. Inhibition of human immunodeficiency virus type 1 long terminal repeat-driven transcription by an in vivo metabolite of oltipraz. implications for antiretroviral therapy Biochem. Biophys. Res. Commun. 221:1996;548-553.
51. Rao C. V., Nayini J., Reddy B. S. Effect of oltipraz [5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] on azoxymethane-induced biochemical changes related to early colon carcinogenesis in male F344 rats. Proc. Soc. Exp. Biol. Med. 197:1991;77-84. a.
52. Rao C. V., Tokomo K., Kelloff G., Reddy B. S. Inhibition by dietary oltipraz of experimental intestinal carcinogenesis induced by azoxymethane in male F344 rats. Carcinogenesis. 12:1991;1051-1055. b.
53. Rao C. V., Rivenson A., Katiwalla M., Kelloff G. J., Reddy B. S. Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats. Cancer Res. 53:1993;2502-2506.
54. Rao C. V., Rivenson A., Zang E., Steele V., Kelloff G., Reddy B. S. Inhibition of 2-amino-1-methyl-6-phenylimidazo[4,5-B]pyridine-induced lymphoma formation by oltipraz. Cancer Res. 56:1996;3395-3398.
55. Smith W. A., Freeman J. W., Gupta R. C. Modulation of dibenz[a, l]pyrene-DNA adduction by chemopreventive agents in the human breast epithelial cell line. Proc. Am. Assoc. Cancer Res. 38:1997;362.
56. Szarka C. E., Pfeiffer G. R., Hum S. T., Everley L. C., Balshem A. M., Moore D. F., Litwin S., Goosenberg E. B., Frucht H., Engstrom P. F., Clapper M. L. Glutathione S-transferase activity and glutathione S-transferase μ expression in subjects with risk for colorectal cancer. Cancer Res. 55:1995;2789-2793.
57. Wargovich M. J., Chen C. D., Jimenez A., Steele V. E., Velasco M., Stephens L. C., Price R., Gray K., Kelloff G. J. Aberrant crypts as a biomarker for colon cancer - evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol. Biomarkers Prev. 5:1996;355-360.
58. Wattenberg L. W., Bueding E. Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (Oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethylnitrosamine and uracil mustard. Carcinogenesis. 7:1986;1379-1381.
59. Yao K.-S., O'Dwyer P. J. Involvement of NF-κB in the induction of NAD(P)H:quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C. Biochem. Pharmacol. 49:1995;275-282.